Abbott reports positive FreeDM2 study results for CGM

​Abbott has announced results from the FreeDM2 RCT, indicating that better glucose outcomes were observed in individuals using the FreeStyle Libre CGM technology for type 2 diabetes.

The post Abbott reports positive FreeDM2 study results for CGM appeared first on Hospital Management.

 

Back to the Featured Stories

Featured Stories

KORU Medical secures certification under EU MDR for infusion pump
J&J reports positive data for Erda-iDRS in bladder cancer
Novartis wins FDA approval for Cosentyx to treat paediatric HS patients
PsiQuantum and National Cancer Center Japan partner on quantum computing
Pilatus Biosciences doses first patient in PLT012 antibody trial

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.

Contact Us